BioCentury
ARTICLE | Company News

Affymetrix previews 4Q12 figures, reducing headcount

January 9, 2013 1:24 AM UTC

Affymetrix Inc. (NASDAQ:AFFX) said it expects 4Q12 revenues of about $84 million, with $18 million in revenues coming from its eBioscience business segment. The Street is expecting 4Q12 revenues of $84.4 million and a non-GAAP loss per share for the quarter of $0.03. The microarray company also said it expects about $295 million in revenues for 2012 -- the Street's estimate is $295.6 million. ...